David Shang
Stock Analyst at Jefferies
(0.99)
# 3,682
Out of 4,423 analysts
14
Total ratings
23.1%
Success rate
-5%
Average return
Main Sectors:
Stocks Rated by David Shang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1875 BioDlink International Company Limited | Maintained: Buy | $4.40 | $3.25 | +35.38% | 1 | Jun 8, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $55.00 | $31.34 | +75.49% | 1 | Mar 31, 2026 | |
| HKG: 9860 Adicon Holdings Limited | Maintained: Buy | $7.00 | $3.77 | +85.68% | 1 | Mar 31, 2026 | |
| HKG: 1066 Shandong Weigao Group Medical Polymer Company Limited | Maintained: Buy | $5.20 → $5.50 | $3.25 | +69.23% | 2 | Mar 30, 2026 | |
| HKG: 1789 AK Medical Holdings Limited | Maintained: Buy | $5.50 → $7.50 | $5.43 | +38.12% | 2 | Mar 30, 2026 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Maintained: Buy | $35.00 → $40.00 | $23.40 | +70.94% | 4 | Mar 30, 2026 | |
| HKG: 3933 The United Laboratories International Holdings Limited | Maintained: Buy | $17.00 → $20.00 | $8.27 | +141.84% | 2 | Sep 5, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Hold | $4.60 | $6.89 | n/a | 1 | Jan 22, 2025 |
BioDlink International Company Limited
Jun 8, 2026
Maintained: Buy
Price Target: $4.40
Current: $3.25
Upside: +35.38%
Hangzhou Tigermed Consulting Co., Ltd
Mar 31, 2026
Maintained: Buy
Price Target: $55.00
Current: $31.34
Upside: +75.49%
Adicon Holdings Limited
Mar 31, 2026
Maintained: Buy
Price Target: $7.00
Current: $3.77
Upside: +85.68%
Shandong Weigao Group Medical Polymer Company Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.20 → $5.50
Current: $3.25
Upside: +69.23%
AK Medical Holdings Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.50 → $7.50
Current: $5.43
Upside: +38.12%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Mar 30, 2026
Maintained: Buy
Price Target: $35.00 → $40.00
Current: $23.40
Upside: +70.94%
The United Laboratories International Holdings Limited
Sep 5, 2025
Maintained: Buy
Price Target: $17.00 → $20.00
Current: $8.27
Upside: +141.84%
CSPC Pharmaceutical Group Limited
Jan 22, 2025
Maintained: Hold
Price Target: $4.60
Current: $6.89
Upside: n/a